Omalizumab (Xolair) - 01/2010

If this is an emergency call 911.

Omalizumab (Xolair)

Abstract

This handout describes omalizumab, an injectable medicine for patients who have allergic asthma. This medicine is used in combination with other inhaled asthma medicines. Side effects and the possibility of anaphylaxis are discussed.

Author

Lung Function Testing

Publisher

University of Washington Medical Center

Date Published (original date)

2010

Revision Date

01/2010

Print Abstract

General Subject

Patient Care Procedures & Instructions

Respiratory Disorders

Specific Subject/Keyword

Anaphylaxis

Asthma

Injections

Medicine Information

Medicine Teaching

Medicines

Side Effects

Languages

English

Record ID

3720